Capgemini SE
Capgemini SE Fundamental Analysis
Capgemini SE (CGEMY) shows moderate financial fundamentals with a PE ratio of 11.38, profit margin of 7.12%, and ROE of 14.10%. The company generates $22.5B in annual revenue with weak year-over-year growth of -1.89%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CGEMY's fundamental strength across five key dimensions:
Efficiency Score
WeakCGEMY struggles to generate sufficient returns from assets.
Valuation Score
ModerateCGEMY shows balanced valuation metrics.
Growth Score
WeakCGEMY faces weak or negative growth trends.
Financial Health Score
ExcellentCGEMY maintains a strong and stable balance sheet.
Profitability Score
WeakCGEMY struggles to sustain strong margins.
Key Financial Metrics
Is CGEMY Expensive or Cheap?
P/E Ratio
CGEMY trades at 11.38 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CGEMY's PEG of 5.19 indicates potential overvaluation.
Price to Book
The market values Capgemini SE at 1.56 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 7.11 times EBITDA. This is generally considered low.
How Well Does CGEMY Make Money?
Net Profit Margin
For every $100 in sales, Capgemini SE keeps $7.12 as profit after all expenses.
Operating Margin
Core operations generate 4.57 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.10 in profit for every $100 of shareholder equity.
ROA
Capgemini SE generates $5.49 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Capgemini SE produces operating cash flow of $2.52B, showing steady but balanced cash generation.
Free Cash Flow
Capgemini SE produces free cash flow of $2.23B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $2.62 in free cash annually.
FCF Yield
CGEMY converts 12.15% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.38
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.19
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.81
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.89
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How CGEMY Stacks Against Its Sector Peers
| Metric | CGEMY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.38 | 34.43 | Better (Cheaper) |
| ROE | 14.10% | 1135.00% | Weak |
| Net Margin | 7.12% | -134808.00% (disorted) | Weak |
| Debt/Equity | 0.89 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 1.18 | 5.77 | Neutral |
| ROA | 5.49% | -310795.00% (disorted) | Weak |
CGEMY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Capgemini SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
52.73%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
90.59%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
38.63%
Industry Style: Growth, Innovation, High Beta
High Growth